Philip Taylor; Investor Relations; Pulse Biosciences Inc. Paul Laviolette; Co-Chairman of the Board, President, Chief Executive Officer; Pulse Biosciences Inc. Jon S ...

Pulse Biosciences, Inc. ( NASDAQ: PLSE) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Philip Trip Taylor - Investor Relations Paul LaViolette - Chief Executive Officer and Co-Chairman of ...

Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings ...

This is a tiny glimpse of the data available in The Pulse of the U.S. Workforce Report by idealis, powered by CivicScience ...

The next generation of business leaders won’t just use AI—they’ll collaborate with it. That’s the driving philosophy behind the new Data Science and AI for Leaders (DSAIL) course, which equips MBA ...

FDA Additional DG reviews progress Govt requests Nepra to reduce power tariffs by Rs1.71/unit Intra-day update: rupee ...

Dan Newhouse, R-Wash., told Agri-Pulse on the sidelines of an American Business Immigration Coalition event on Capitol Hill. He said border policies were previously one of the biggest reasons ...

Findings show measured declines in energy use intensity across seven property types, cumulative reductions since 2019 across ...

Northbridge's approach to flexibility, well-being, and career growth is turning employee satisfaction into success ...

The former First Lady of Ekiti State, Bisi Adeleye-Fayemi, has called for urgent action to bridge the gender equality gap in Nigeria, highlighting both progress and persistent challenges in ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced business updates ...